Chlamydia pneumoniae infection is associated with coronary artery disease but not implicated in inducing plaque instability

International Journal of Cardiology

Volumn 95, Issue 1, 2004, Pages 95-99

  Romano, Silvio ^a,b   Penco, Maria ^b   Fratini, Simona ^b   Di Pietro, Marisa ^a   Sessa, Rosa ^a   Del Piano, Massimo ^a   Fedele, Francesco ^a   Dagianti, Armando ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Coronary artery disease; Unstable angina

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REINFECTION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ANTIBODY SPECIFICITY; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INCIDENCE; ITALY; MALE; MIDDLE AGED; STATISTICS;

EID: 2442672526     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.05.014     Document Type: Article

References (32)

1. Melnick J.L., Adam E., Debakey M.E. Cytomegalovirus and atherosclerosis. Eur. Heart J. 14(suppl K):1993;30-38
2. Mendall M.A., Goggin P.M., Molineaux N., et al. Relation of Helicobacter pylori and coronary heart disease. British Heart J. 71:1994;437-439
3. Saikku P. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur. Heart J. 14:1993;62-65
4. Roivainen M., Viik-Kajander M., Palosuo T., et al. Infections, inflammation and the risk of coronary heart disease. Circulation. 101:2000;252-257
5. Gupta S. Chronic infection in the aetiology of atherosclerosis - focus on Chlamydia pneumoniae. Atherosclerosis. 143:1999;1-6
6. Sessa R., Di Pietro M., Santino I., et al. Chlamydia pneumoniae infection and atherosclerotic coronary disease. Am. Heart J. 137:1999;1116-1119
7. Penco M., Varveri A., Aurigemma G., et al. Acute and Chronic Chlamydia pneumoniae infection in unstable angina. J. Am. Coll. Cardiol. 31(5):1998;166. [supp. C]
8. Saikku P., Leinonen M., Mattila K., et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:1988;983-986
9. Thom D.H., Grayston J.T., Siscovick D.S., Wang S.P., Weiss N.S., Daling J.R. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA. 268:1992;68-72
10. Linnanmäki E., Leinonen M., Mattila K., Markku S.N., Valtonen V., Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in pts with chronic coronary heart disease. Circulation. 87:1993;1130-1134
11. Wong Y., Dawkins K.D., Ward M.E. Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease. J. Am. Coll. Cardiol. 34:1999;1435-1439
12. Kaski J.C., Camm A.J. Chlamydia pneumoniae infection and coronary artery disease. J. Am. Coll. Cardiol. 34:1999;1440-1442
13. Gupta S., Leatham E.W., Carrington D., Mendall M.A., Kaski C., Camm J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation. 96:1997;404-407
14. Gurfinkel E., Bozovich G., Daroca A., Beck E., Mautner B. for the Roxis study group Randomized trial of roxitromycin in non-Q wave coronary syndromes: ROXIS pilot study. Lancet. 350:1997;404-407
15. Gurfinkel E., Bozovich G., Beck E., et al. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes - the final report of the ROXIS study. Eur. Heart J. 20:1999;121-127
16. Muhlestein J.B., Anderson J.L., Carlquist J.F., et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the academic study. Circulation. 102:2000;1755-1760
17. Dunne M.W. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax - azithromycin - for atherosclerosis and its related disorders) trial. J. Infect. Dis. 181(Suppl 3):2000;s572-s578
18. Nobel M., De Torrente A., Peter O., Genne D. No serological evidence of association between Chlamydia pneumoniae infection and acute coronary heart disease. Scand. J. Infect. Dis. 31:1999;261-264
19. Bauriedel G., Welsch U., Likungu J.A., Welz A., Luderitz B. Chlamydia pneumoniae in coronary plaques: increase detection with acute coronary syndromes. Dtsch. Med. Wochenschr. 124:1999;375-380
20. Caligiuri G., Liuzzo G., Biasucci L.M., Maseri A. Immune system activation follows inflammation in unstable angina: pathogenetic implications. J. Am. Coll. Cardiol. 32:1998;1295-1304
21. Dowell S.F., Peeling R.W., Boman J., et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin. Infect. Dis. 33:2001;492-503
22. Saikku P., Leinonen M., Tenkanen L., et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann. Intern. Med. 116:1992;273-278
23. Blasi F., Cosentini R., Raccanelli R., Massari F.M., Arosio C., Tarsia P., et al. A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest. 112:1997;309-312
24. Hoffmeister A., Rothenbacher D., Wanner P., et al. Seropositivity to Chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease. Negative results of a case-control study. J. Am. Coll. Cardiol. 35:2000;112-118
25. Cellesi C., Sansoni A., Casini S., et al. Chlamydia pneumoniae antibodies and angiographically demonstrated coronary artery disease in a sample population from Italy. Atherosclerosis. 145:1999;81-85
26. Ridker M., Kundsin R.B., Stampfer M.J., et al. Prospective study of Chlamydia pneumoniae IgG seropositivity and risk of future myocardial infarction. Circulation. 99:1999;1161-1164
27. Wald N.J., Law M.R., Morris J.K., Zhou X., Wong Y., Ward M.E. Chlamydia pneumoniae infection and mortality from ischemic heart disease: large prospective study. BMJ. 321:2000;204-207
28. Danesh J., Whincup P., Walker M., et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ. 321:2000;208-213
29. Leinonen M. Pathogenetic mechanism and epidemiology of Chlamydia pneumoniae. Eur. Heart J. 14:1993;57-61
30. Gurfinkel E. Inflammation, infection, or both in atherosclerosis: the ROXIS trial in perspective. J. Infect. Dis. 181(suppl 3):2000;s566-s568
31. Maseri A. Antibiotics for acute coronary syndromes: are we ready for megatrials? Eur. Heart J. 20:1999;89-92
32. Chandra H.R., Choudary N., O'Neill C., Boura J., Timmis G.C., O'Neill W.W. Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS). Am. J. Cardiol. 88:2001;214-218